期刊文献+

TLR4/MyD88非依赖信号通路在强直性脊柱炎患者中的表达及临床意义

Expression and clinical significance of TLR4/MyD88 independent signaling pathway in patients with ankylosing spondylitis
下载PDF
导出
摘要 目的检测细胞Toll样受体4(TLR4)/髓样分化因子88(MyD88)非依赖信号通路在强直性脊柱炎(AS)患者血清及滑膜组织的表达情况,探讨TLR4/MyD88非依赖信号通路在AS起病及病情活动中的作用,为治疗AS提供新思路。方法选取2019年1月至2021年12月在蚌埠医学院第二附属医院风湿免疫科就诊的AS患者46例作为AS组,选取同期健康体检者30例作为健康对照组;选取13例行髋关节置换术AS患者滑膜组织作为AS手术组,选取10例同期髋关节创伤性骨折患者滑膜组织作为对照组。检测2组研究对象血清γ-干扰素(IFN-γ)水平,分析IFN-γ与C反应蛋白(CRP)、红细胞沉降率和AS病情活动度评分(ASDAS)-CRP的相关性;采用实时荧光定量聚合酶链反应法测定2组患者滑膜组织TLR4/MyD88非依赖信号通路相关分子——TLR4、Toll样受体相关分子、TIR域含适配器诱导β-干扰素、核因子-κB-p65及末端炎症因子——IFN-γmRNA表达情况。结果AS组患者血清IFN-γ水平明显高于健康对照组,血清IFN-γ水平与红细胞沉降率、CRP、ASDAS-CRP水平均呈正相关,AS手术组患者滑膜组织TLR4/MyD88非依赖信号通路重要节点分子——TLR4、Toll样受体相关分子、TIR域含适配器诱导β-干扰素、核因子-κB-p65、IFN-γmRNA表达水平均明显高于对照组,差异均有统计学意义(P<0.05)。结论TLR4/MyD88非依赖信号通路可能在AS起病及病情活动中起到重要作用,为治疗AS提供了新思路。 Objective To investigate the expression of TLR4/MyD88 independent signal pathway in serum and synovial tissue of the patients with ankylosing spondylitis(AS),and to explore the role of TLR4/MyD88 independent signal pathway in the onset and activity of AS to provide the new ideas for the treatment of AS.Methods Forty-six patients with AS treated in the Second Affiliated Hospital of Bengbu Medical College from Janaury 2019 to December 2021 were selected as the AS group,and the healthy subjects undergoing physical exmination at the same tine were selected as the healthy control group.The synovial tissue in 13 AS cases of hip replacement was selected as the AS operation group and the synovial tissue of 10 patients with hip joint traumatic fracture was selected as the control group.The serum IFN-γlevel in the two groups was detected,and the correlation between IFN-γwith CRP,ESR and ASDAS-CRP was analyzed.The mRNA expression levels of TLR4/MyD88 non-dependent signaling pathway related molecules TLR4,TRAM,TRIF,NF-κB-p65 and IFN-γin the patients with AS were determined by real-time fluorescence quantitative PCR.Results(1)The serum IFN-γlevel in the patients with AS was significantly higher than that in the healthy control group.The serum IFN-γlevel in AS patients was positively correlated with ESR,CRP and ASDAS-CRP(P<0.001).The mRNA expression levels of TLR4,TRAM,TRIF,NF-κB-p65 and IFN-γin synovium tissues of the AS group were significantly higher than those in the control group,and the differences were statistically significant(P<0.001).Conclusion TLR4/MyD88 independent signaling pathway may play an important role in the onset and activity of AS,which may provide the new ideas for the treatment of AS.
作者 杨大伟 臧欢欢 杨慧敏 孙旭 李莹 袁伶俐 YANG Dawei;ZANG Huanhuan;YANG Huimin;SUN Xu;LI Ying;YUAN Lingli(Department of Rheumatism and Immunology,Second Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui 233000,China;Department of Pediatrics,First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui 233004,China;Department of Orthopedics,Second Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui 233000,China)
出处 《现代医药卫生》 2023年第10期1670-1674,共5页 Journal of Modern Medicine & Health
基金 蚌埠医学院自然科学类项目/重点项目(2020byzd194)。
关键词 强直性脊柱炎 滑膜 信号通路 细胞Toll样受体4 Γ-干扰素 Ankylosing spondylitis Synovial Signal pathway TLR4 IFN-γ
  • 相关文献

参考文献4

二级参考文献33

  • 1Braun J,Sieper J. Ankylosing spondylitis[J]. Lancet, 2007,369(9570):1379-1390.
  • 2Lukas C,Landewe R, Sieper J, et al. Development of an ASAS- endorsed disease activity score(ASDAS)in patients with ankylosing spondylitis[J]. Ann Rheum Dis,2009,68(1):18-24.
  • 3van der Heijde D,Lie E,Kvien TK, et al. ASDAS,a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis[J]. Ann Rheum Dis,2009, 68(12):1811-1818.
  • 4Machado P,Landewe R. Spondyloarthritis: Is it time to replace BASDAI with ASDAS?[J]. Nat Rev Rheumatol, 2013, 9(7):388-390.
  • 5Au YL,Wong WS, Mok MY, et al. Disease activity assessment in ankylosing spondylitis in a Chinese cohort : BASDAI or ASDAS?[J]. Clin Rheumatol, 2014,33(8):1127-1134.
  • 6Kilic E,Kilic G, Akgul O,et al. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score(ASDAS)in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study[J]. Rheumatol Int, 2015,35(6):981-989.
  • 7Machado P,Landewe R,Lie E,et al. Ankylosing Spondylitis Disease Activity Score(ASDAS): defining cut-off values for disease activity states and improvement scores[J]. Ann Rheum Dis, 2011,70(1):47-53.
  • 8Pedersen SJ, S0rensen U, Gamero P,et al. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFa inhibitors[J]. Ann Rheum Dis, 2011,70(8):1375-1381.
  • 9Machado PM,Landewe RB, van der Heijde DM. Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score : results from OMERACT 10[J]. J Rheumatol, 2011, 38(7):1502-1506.
  • 10Machado P,Navarro-Compdn V,Landew6 R,et al. Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high- sensitivity c-reactive protein is used: an analysis in the DESIR cohort[J]. Arthritis Rheumatol,2015 , 67(2):408-413.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部